FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098413006> ?p ?o ?g. }

• W2098413006 endingPage "2376" @default.
• W2098413006 startingPage "2361" @default.
• W2098413006 abstract "Acute Escherichia coli mastitis is one of the major sources of economic loss in the dairy industry due to reduced milk production, treatment costs, discarded milk, and occasional fatal disease. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used as adjunctive therapy to antibiotics. The objective of the current study was to evaluate the effect of carprofen treatment following infusion of Escherichia coli into the mammary glands of primiparous cows during the periparturient period. Severity of mastitis was scored based on the average milk production in the uninfected quarters on d +2 postinoculation and a clinical severity score. Carprofen was administered intravenously at 9 h postchallenge, when clinical signs of mastitis appeared. In previous work, efficacy of NSAIDs was mainly evaluated using clinical symptoms. In the present study, the effect of carprofen on innate immune response was also assessed by quantification of inflammatory mediators. All primiparous cows reacted as moderate responders throughout the experimental period. Primiparous cows were intramammarily inoculated with 1 x 10(4) cfu of E. coli P4:O32 in 2 left quarters. Analysis of blood and milk parameters, including IL-8, complement component C5a, lipopolysaccharide-binding protein (LBP), soluble CD14, prostaglandin E2, and thromboxane B2 was performed from d 0 to d +6 relative to intramammary inoculation. Rectal temperature in carprofen-treated animals was lower than in control animals at 3 and 6 h posttreatment. Treatment also restored the decreased reticulorumen motility that occurs during E. coli mastitis to preinfection levels faster than in control animals. Carprofen treatment resulted in an earlier normalization of the clinical severity score. Eicosanoid (prostaglandin E2 and thromboxane B2) production in milk tended to be inhibited by carprofen. No significant differences in the kinetic patterns of somatic cell count, IL-8, complement component C5a, LBP, and soluble CD14 were observed. In conclusion, carprofen treatment improved general clinical condition by effective antipyrexia and restoration of reticulorumen motility but did not significantly inhibit eicosanoid production. Carprofen treatment did not result in a significant decrease of chemotactic inflammatory mediators, IL-8 and C5a, and early innate immune molecules, sCD14 and LBP. Therefore, major modulatory effects from NSAID administration were not observed in this mastitis model, although a larger study might confirm some apparent trends obtained in the present results." @default.
• W2098413006 created "2016-06-24" @default.
• W2098413006 creator A5001085423 @default.
• W2098413006 creator A5023360095 @default.
• W2098413006 creator A5034078175 @default.
• W2098413006 creator A5052096892 @default.
• W2098413006 creator A5066785648 @default.
• W2098413006 creator A5074079751 @default.
• W2098413006 creator A5079570045 @default.
• W2098413006 date "2005-07-01" @default.
• W2098413006 modified "2023-10-05" @default.
• W2098413006 title "Effect of Carprofen Treatment Following Experimentally Induced Escherichia coli Mastitis in Primiparous Cows" @default.
• W2098413006 cites W1539392991 @default.
• W2098413006 cites W1964710766 @default.
• W2098413006 cites W1966864132 @default.
• W2098413006 cites W1968334024 @default.
• W2098413006 cites W1969275369 @default.
• W2098413006 cites W1977404830 @default.
• W2098413006 cites W1995082781 @default.
• W2098413006 cites W2012126208 @default.
• W2098413006 cites W2026509760 @default.
• W2098413006 cites W2028776576 @default.
• W2098413006 cites W2030393676 @default.
• W2098413006 cites W2031529931 @default.
• W2098413006 cites W2033745905 @default.
• W2098413006 cites W2034060375 @default.
• W2098413006 cites W2036545552 @default.
• W2098413006 cites W2042317672 @default.
• W2098413006 cites W2053423208 @default.
• W2098413006 cites W2058522802 @default.
• W2098413006 cites W2064818626 @default.
• W2098413006 cites W2067328369 @default.
• W2098413006 cites W2074168467 @default.
• W2098413006 cites W2078563613 @default.
• W2098413006 cites W2089163359 @default.
• W2098413006 cites W2094054189 @default.
• W2098413006 cites W2098444662 @default.
• W2098413006 cites W2098947142 @default.
• W2098413006 cites W2110215475 @default.
• W2098413006 cites W2121806673 @default.
• W2098413006 cites W2122054271 @default.
• W2098413006 cites W2122709899 @default.
• W2098413006 cites W2150418093 @default.
• W2098413006 cites W2159666172 @default.
• W2098413006 cites W2164896346 @default.
• W2098413006 cites W2165626477 @default.
• W2098413006 cites W2166054948 @default.
• W2098413006 doi "https://doi.org/10.3168/jds.s0022-0302(05)72914-3" @default.
• W2098413006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15956299" @default.
• W2098413006 hasPublicationYear "2005" @default.
• W2098413006 type Work @default.
• W2098413006 sameAs 2098413006 @default.
• W2098413006 citedByCount "56" @default.
• W2098413006 countsByYear W20984130062012 @default.
• W2098413006 countsByYear W20984130062013 @default.
• W2098413006 countsByYear W20984130062014 @default.
• W2098413006 countsByYear W20984130062015 @default.
• W2098413006 countsByYear W20984130062016 @default.
• W2098413006 countsByYear W20984130062017 @default.
• W2098413006 countsByYear W20984130062018 @default.
• W2098413006 countsByYear W20984130062020 @default.
• W2098413006 countsByYear W20984130062021 @default.
• W2098413006 countsByYear W20984130062022 @default.
• W2098413006 countsByYear W20984130062023 @default.
• W2098413006 crossrefType "journal-article" @default.
• W2098413006 hasAuthorship W2098413006A5001085423 @default.
• W2098413006 hasAuthorship W2098413006A5023360095 @default.
• W2098413006 hasAuthorship W2098413006A5034078175 @default.
• W2098413006 hasAuthorship W2098413006A5052096892 @default.
• W2098413006 hasAuthorship W2098413006A5066785648 @default.
• W2098413006 hasAuthorship W2098413006A5074079751 @default.
• W2098413006 hasAuthorship W2098413006A5079570045 @default.
• W2098413006 hasBestOaLocation W20984130061 @default.
• W2098413006 hasConcept C126322002 @default.
• W2098413006 hasConcept C140793950 @default.
• W2098413006 hasConcept C142724271 @default.
• W2098413006 hasConcept C2776344049 @default.
• W2098413006 hasConcept C2776977481 @default.
• W2098413006 hasConcept C2778384902 @default.
• W2098413006 hasConcept C2778754761 @default.
• W2098413006 hasConcept C2779170986 @default.
• W2098413006 hasConcept C2780741920 @default.
• W2098413006 hasConcept C54355233 @default.
• W2098413006 hasConcept C71924100 @default.
• W2098413006 hasConcept C86803240 @default.
• W2098413006 hasConcept C98274493 @default.
• W2098413006 hasConceptScore W2098413006C126322002 @default.
• W2098413006 hasConceptScore W2098413006C140793950 @default.
• W2098413006 hasConceptScore W2098413006C142724271 @default.
• W2098413006 hasConceptScore W2098413006C2776344049 @default.
• W2098413006 hasConceptScore W2098413006C2776977481 @default.
• W2098413006 hasConceptScore W2098413006C2778384902 @default.
• W2098413006 hasConceptScore W2098413006C2778754761 @default.
• W2098413006 hasConceptScore W2098413006C2779170986 @default.
• W2098413006 hasConceptScore W2098413006C2780741920 @default.
• W2098413006 hasConceptScore W2098413006C54355233 @default.
• W2098413006 hasConceptScore W2098413006C71924100 @default.
• W2098413006 hasConceptScore W2098413006C86803240 @default.

• next